Home/lupin/Nilesh Gupta
NG

Nilesh Gupta

Managing Director

lupin

lupin Pipeline

DrugIndicationPhase
Sugammadex InjectionNeuromuscular blockade reversalApproved (Tentative)
Pitolisant TabletsNarcolepsyApproved (Tentative)
Semaglutide InjectionType 2 Diabetes, ObesityMarket
Novel GLP-1 Receptor AgonistMetabolic DisordersPre-clinical/Clinical
Biosimilars PortfolioOncology, ImmunologyVarious
Plasil®GastroenterologyMarket